Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

BUY
$1.22 - $4.38 $484,943 - $1.74 Million
397,495 Added 36.95%
1,473,218 $2.25 Million
Q3 2017

Nov 14, 2017

BUY
$6.08 - $7.0 $6.54 Million - $7.53 Million
1,075,723
1,075,723 $6.92 Million

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Park West Asset Management LLC Portfolio

Follow Park West Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park West Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park West Asset Management LLC with notifications on news.